Profile
Kedar Purushottam Phadke worked as a Secretary at Kirloskar Pneumatic Co. Ltd.
in 2009 and as a Secretary & Compliance Officer at Emcure Pharmaceuticals Ltd.
from 2010 to 2014.
He also worked as a Secretary & Compliance Officer at Thermax Ltd.
from 2017 to 2021.
Former positions of Kedar Purushottam Phadke
Companies | Position | End |
---|---|---|
THERMAX LIMITED | Compliance Officer | 2021-08-18 |
Emcure Pharmaceuticals Ltd.
Emcure Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Emcure Pharmaceuticals Ltd. engages in developing, manufacturing and marketing of pharmaceutical products. Its products include Nucron, Xennea, Xennex, Nifirex, Criante and Oncocare. The company offers calcium channel blockers, beta blockers, hypotensive combinations, statins, anti-coagulants, and diuretic combinations for cardiology. Its product portfolio includes orals, injectable and biologics, as well as an mRNA platform through which it is developing a COVID-19 vaccine. The company was founded by Satish Ramanlal Mehta on April 16, 1981 and is headquartered in Pune, India. | Corporate Secretary | - |
KIRLOSKAR PNEUMATIC COMPANY LIMITED | General Counsel | - |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 2 |
---|---|
KIRLOSKAR PNEUMATIC COMPANY LIMITED | Producer Manufacturing |
THERMAX LIMITED | Producer Manufacturing |
Private companies | 1 |
---|---|
Emcure Pharmaceuticals Ltd.
Emcure Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Emcure Pharmaceuticals Ltd. engages in developing, manufacturing and marketing of pharmaceutical products. Its products include Nucron, Xennea, Xennex, Nifirex, Criante and Oncocare. The company offers calcium channel blockers, beta blockers, hypotensive combinations, statins, anti-coagulants, and diuretic combinations for cardiology. Its product portfolio includes orals, injectable and biologics, as well as an mRNA platform through which it is developing a COVID-19 vaccine. The company was founded by Satish Ramanlal Mehta on April 16, 1981 and is headquartered in Pune, India. | Health Technology |
- Stock Market
- Insiders
- Kedar Purushottam Phadke